Kirkland & Ellis represented GTCR in a partnership with Gregory T. Lucier to form Corza Health, Inc., which GTCR announced on March 20, 2019. The new company will focus on acquiring companies and assets as part of a strategy to build a market-leading healthcare business with a particular focus on the broader life sciences and medical technology sector. GTCR will invest in Corza Health from GTCR Fund XII, a private equity fund with $5.25 billion of equity capital commitments.
Read the company press release
The Kirkland team was led by transactional partners Sanford Perl and Michael Weed and associate Neil Vohra, intellectual property partner Jordan Heinz, and technology & IP transactions partner Matthew Lovell.